RLI Corp.
RLIRLI Corp. is cheap for a reason. The P/BV sits at the 11th percentile of its own range, and the quarters are still getting worse.
The sharpest disagreement: the P/BV sits at the 11th percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn.
The price is topping out (12 weeks in) while the P/BV sits at the 11th percentile of its own 5-year range. Underneath, the last four quarters read deteriorating — profit −16.7% year on year, with the the net margin at 11.9%. What settles it: whether the quarters turn before the discount closes.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
RLI Corp. trades at $60.5, losing momentum at the top and 12 weeks into that stage. That is +2.3% against its own 200-day average. It sits at 69% of a 52-week range of $49 to $66. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks.
Today the stock is losing momentum at the top — week 12 of stage 3. At $60.5 it trades +2.3% versus its 200-day average and sits at 69% of its 52-week range ($49–$66).
Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +78% while the S&P 500 moved +255% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 9 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
RLI Corp. trades at 3.2× P/BV, near the bottom of its own range — cheaper only 11% of the time. Its long-run median P/BV is 4.3×, measured across 5.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 3.2× is near the bottom of its own range — cheaper only 11% of the time, against a long-run median of 4.3× measured over 5.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year book value grew while the price moved −6.3% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +3.4%/yr price move, ~+7.0%/yr came from book-value growth and ~−3.6 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
RLI Corp. reads as improving on its fundamental arc. Improving — profit growth bottomed 8 quarters ago at −49.2% and has held its recovery at +35.7%, ROE lifting at 21.1%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +6.2% | +3.4% | — | — |
| Profit | +14.3% | −11.6% | — | — |
| EPS | +16.8% | −11.8% | — | — |
| Stock price | −6.3% | −4.0% | +3.4% | +6.2% |
4-Factor Sector Score
52.6/100 — rank 12 of 30 in Insurance - Property & Casualty · 60% evidence confidence
RLI Corp. scores 52.6 out of 100 against the 30 companies it is compared with in Insurance - Property & Casualty, ranking 12. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 21 + 17.1 + 6.5 + 8 = 52.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
RLI Corp. reported $0.4 B of income in the Mar 26 quarter, +2.4% year on year. That is the 4th straight quarter of year-on-year growth. Over 4 years it has compounded at 12.3% a year. The last full year, FY25, came in at $1.9 B. The last four reported quarters add to $1.9 B.
FY25 revenue came in at $1.9 B (+6.2% on the year), capping 4 years at 12.3% compound. The latest quarter (Mar 26) printed $0.4 B, +2.4% year on year — the 4th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +9.2% growth against the decade's 12.3% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +9.2% over the last 4 quarters against +9.7%/yr over the last 8 — stabilising; TTM profit +35.7% vs +7.3%/yr — accelerating.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
RLI Corp.'s net margin is 11.9% in the Mar 26 quarter, −2.7 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 19.8% to 34.1%. The current quarter is running below every full year in that window.
The latest quarter's net margin is 11.9%, −2.7 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 19.8%–34.1%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
RLI Corp. earned $0.1 B of net profit in the Mar 26 quarter, −16.7% year on year. Full-year FY25 profit was $0.4 B. The 4-year compound rate is 9.3%. That is 11.9% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.
Mar 26 profit was $0.1 B, −16.7% year on year. On the full year, FY25 printed $0.4 B (+14.3%), and the 4-year compound rate is 9.3%.
🚨 Why profit moved: revenue contributed +2.4% and the margin −2.7 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +44.6% vs revenue +9.2%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for RLI Corp., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
RLI Corp.'s revenue grew +6.2% in FY25 to $1.9 B, so the book is growing. The latest quarter ran +2.4% year on year. The net margin on that income is 11.9%, −2.7 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $1.9 B, +6.2% on the year, and the latest quarter ran +2.4% year on year. The net margin on that revenue is 11.9% this quarter (−2.7 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
RLI Corp. earns a return on equity of 23% in FY25. Its trough over the ladder below was 21% in FY23. On the asset side every $100 of the balance sheet earned about $5.67, which is the return before leverage is applied.
FY25 ROE came in at 23%, recovered from a FY23 trough of 21%. On assets, the latest reading is about 5.67% — every $100 the bank deploys earns roughly $5.67 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 9.3% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
RLI Corp. paid $0.64 per share over the last four reported quarters, up 6.7% on a year ago. The most recent declaration was $0.16 for Mar 26. Against the current price of $60.5 that is a trailing yield of 1.06%, measured on dividends already paid rather than on a forecast.
RLI Corp. paid $0.64 per share across the last four reported quarters, most recently $0.16 for Mar 26. That is up 6.7% against the same quarter a year earlier. Against the current price of $60.5 the trailing twelve months work out to 1.06% — trailing dividends measured against today's price, not a forward estimate.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
10.3% of RLI Corp.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 13.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 10.3% of the float is sold short, and at typical trading volumes it would take about 13.4 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
RLI Corp.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Slide Insurance Holdings, Inc.SLDE | 73.5/100Favorable setup60% evidence | BREAKING OUT | 20.7/35 Income — · PAT — 26% evidence | 19.8/25 ROA 4.2% · ROE 13.1% · GNPA — 68% evidence | 13.3/20 P/BV 1.87× · P/BV÷ROE 0.14 70% evidence | 19.7/20 RS sector 27% · RS bench 30.6% · 1Y 74.4%9 of 12 weeks ahead 100% evidence |
| Exact sum: 20.7 + 19.8 + 13.3 + 19.7 = 73.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2The Allstate CorporationALL | 69.8/100Favorable setup80% evidence | LEADER | 24.8/35 Income 5.9% · PAT 100% 81% evidence | 17.3/25 ROA 2.8% · ROE 11.3% · GNPA — 68% evidence | 12.7/20 P/BV 1.79× · P/BV÷ROE 0.16 70% evidence | 15.0/20 RS sector 5.7% · RS bench 8.7% · 1Y 23.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 24.8 + 17.3 + 12.7 + 15 = 69.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3The Travelers Companies, Inc.TRV | 61.2/100Mixed-positive evidence80% evidence | BREAKING OUT | 21.1/35 Income 2.4% · PAT 58.3% 81% evidence | 14.8/25 ROA 1.6% · ROE 7% · GNPA — 68% evidence | 7.5/20 P/BV 2.08× · P/BV÷ROE 0.3 70% evidence | 17.8/20 RS sector 11.8% · RS bench 15% · 1Y 36.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 14.8 + 7.5 + 17.8 = 61.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4HCI Group, Inc.HCI | 59.2/100Mixed-positive evidence62% evidence | BREAKING OUT | 22.9/35 Income 22.1% · PAT 100% 55% evidence | 13.6/25 ROA — · ROE 9.9% · GNPA — 34% evidence | 11.5/20 P/BV 1.83× · P/BV÷ROE 0.18 70% evidence | 11.2/20 RS sector -2.2% · RS bench 0.5% · 1Y 2.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 13.6 + 11.5 + 11.2 = 59.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5United Fire Group, Inc.UFCS | 57.4/100Mixed-positive evidence70% evidence | LEADER | 23.8/35 Income 10.6% · PAT 97% 71% evidence | 9.3/25 ROA 0.9% · ROE 3.4% · GNPA — 68% evidence | 7.9/20 P/BV 1× · P/BV÷ROE 0.29 70% evidence | 16.4/20 RS sector 20.2% · RS bench 23.8% · 1Y 75.2%12 of 12 weeks ahead 70% evidence |
| Exact sum: 23.8 + 9.3 + 7.9 + 16.4 = 57.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Cincinnati Financial CorporationCINF | 57.0/100Mixed-positive evidence80% evidence | ASLEEP | 29.1/35 Income 19.6% · PAT 82.8% 81% evidence | 14.9/25 ROA 2.1% · ROE 6.9% · GNPA — 68% evidence | 8.6/20 P/BV 1.72× · P/BV÷ROE 0.25 70% evidence | 4.4/20 RS sector -6.5% · RS bench -3.8% · 1Y 9.4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 29.1 + 14.9 + 8.6 + 4.4 = 57 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -6.5% and the one-year return is 9.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 7Mercury General CorporationMCY | 55.1/100Mixed-positive evidence67% evidence | ASLEEP | 22.4/35 Income 9.7% · PAT 100% 45% evidence | 15.1/25 ROA 2.1% · ROE 8.6% · GNPA — 68% evidence | 9.8/20 P/BV 1.89× · P/BV÷ROE 0.22 70% evidence | 7.8/20 RS sector -1.9% · RS bench 1% · 1Y 28.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 22.4 + 15.1 + 9.8 + 7.8 = 55.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8The Hanover Insurance Group, Inc.THG | 54.3/100Mixed-positive evidence60% evidence | LEADER | 18.1/35 Income — · PAT — 26% evidence | 13.5/25 ROA 1.6% · ROE 5.6% · GNPA — 68% evidence | 5.9/20 P/BV 2.03× · P/BV÷ROE 0.36 70% evidence | 16.8/20 RS sector 10.8% · RS bench 13.9% · 1Y 32.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 13.5 + 5.9 + 16.8 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Skyward Specialty Insurance Group, Inc.SKWD | 53.6/100Mixed-positive evidence76% evidence | LEADER | 20.4/35 Income 28.9% · PAT 43.5% 71% evidence | 11.6/25 ROA 1.1% · ROE 4.8% · GNPA — 68% evidence | 6.6/20 P/BV 1.59× · P/BV÷ROE 0.33 70% evidence | 15.0/20 RS sector 5.1% · RS bench 7.9% · 1Y 20.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 11.6 + 6.6 + 15 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Palomar Holdings, Inc.PLMR | 53.0/100Mixed-positive evidence62% evidence | BREAKING OUT | 22.0/35 Income 60.4% · PAT 47% 55% evidence | 11.8/25 ROA — · ROE 4.9% · GNPA — 34% evidence | 3.3/20 P/BV 3.3× · P/BV÷ROE 0.67 70% evidence | 15.9/20 RS sector 2.9% · RS bench 5.7% · 1Y 21.5%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22 + 11.8 + 3.3 + 15.9 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Assurant, Inc.AIZ | 52.7/100Mixed-positive evidence76% evidence | LEADER | 22.6/35 Income 9% · PAT 49% 71% evidence | 10.8/25 ROA 0.8% · ROE 4.9% · GNPA — 68% evidence | 5.7/20 P/BV 1.84× · P/BV÷ROE 0.38 70% evidence | 13.6/20 RS sector 6.5% · RS bench 9.6% · 1Y 35.3%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 10.8 + 5.7 + 13.6 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12RLI Corp.this pageRLI | 52.6/100Mixed-positive evidence60% evidence | BREAKING OUT | 21.0/35 Income — · PAT — 26% evidence | 17.1/25 ROA 2.7% · ROE 9.6% · GNPA — 68% evidence | 6.5/20 P/BV 3.09× · P/BV÷ROE 0.32 70% evidence | 8.0/20 RS sector -7.9% · RS bench -5.5% · 1Y -6.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 17.1 + 6.5 + 8 = 52.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 13W. R. Berkley CorporationWRB | 51.6/100Mixed-positive evidence80% evidence | TURNING | 12.8/35 Income 4.3% · PAT 9.5% 81% evidence | 20.8/25 ROA 3.6% · ROE 21.2% · GNPA — 68% evidence | 13.5/20 P/BV 2.79× · P/BV÷ROE 0.13 70% evidence | 4.5/20 RS sector -9.4% · RS bench -6.9% · 1Y -4.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 20.8 + 13.5 + 4.5 = 51.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 14Kinsale Capital Group, Inc.KNSL | 48.6/100Mixed-negative evidence60% evidence | BREAKING OUT | 19.0/35 Income — · PAT — 26% evidence | 18.0/25 ROA 3% · ROE 9.4% · GNPA — 68% evidence | 4.9/20 P/BV 3.69× · P/BV÷ROE 0.39 70% evidence | 6.7/20 RS sector -11.3% · RS bench -9% · 1Y -15.9%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 18 + 4.9 + 6.7 = 48.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 15Markel Group Inc.MKL | 45.7/100Mixed-negative evidence60% evidence | BASING | 20.8/35 Income — · PAT — 26% evidence | 14.6/25 ROA 1.8% · ROE 6.3% · GNPA — 68% evidence | 8.6/20 P/BV 1.28× · P/BV÷ROE 0.2 70% evidence | 1.7/20 RS sector -16.8% · RS bench -14.5% · 1Y -7.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 14.6 + 8.6 + 1.7 = 45.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Hagerty, Inc.HGTY | 44.9/100Mixed-negative evidence64% evidence | BREAKING OUT | 13.5/35 Income 15.4% · PAT 12.4% 71% evidence | 4.9/25 ROA -0.6% · ROE -2.2% · GNPA — 68% evidence | 9.1/20 P/BV 4.87× · P/BV÷ROE — 10% evidence | 17.4/20 RS sector 6% · RS bench 8.8% · 1Y 9.3%10 of 12 weeks ahead 100% evidence |
| Exact sum: 13.5 + 4.9 + 9.1 + 17.4 = 44.9 · Decision use: Price leads the evidence: RS versus the benchmark is 8.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 17The Progressive CorporationPGR | 43.5/100Mixed-negative evidence80% evidence | FADING | 13.1/35 Income 10.5% · PAT 12.1% 81% evidence | 17.9/25 ROA 2.8% · ROE 9.9% · GNPA — 68% evidence | 5.2/20 P/BV 3.7× · P/BV÷ROE 0.37 70% evidence | 7.3/20 RS sector -7.6% · RS bench -5% · 1Y -10.5%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 17.9 + 5.2 + 7.3 = 43.5 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 18Old Republic International CorporationORI | 43.1/100Mixed-negative evidence60% evidence | BREAKING OUT | 20.5/35 Income — · PAT — 26% evidence | 11.8/25 ROA 1.1% · ROE 5.3% · GNPA — 68% evidence | 7.3/20 P/BV 1.64× · P/BV÷ROE 0.31 70% evidence | 3.5/20 RS sector -10.5% · RS bench -8% · 1Y 2.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 11.8 + 7.3 + 3.5 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Safety Insurance Group, Inc.SAFT | 41.8/100Thin evidence · provisional58% evidence | BREAKING OUT | 10.1/35 Income 10.8% · PAT -13.7% 71% evidence | 5.8/25 ROA -0.6% · ROE -1.7% · GNPA — 68% evidence | 9.8/20 P/BV 1.25× · P/BV÷ROE — 10% evidence | 16.1/20 RS sector 19.2% · RS bench 22.4% · 1Y 44.6%9 of 12 weeks ahead 70% evidence |
| Exact sum: 10.1 + 5.8 + 9.8 + 16.1 = 41.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20White Mountains Insurance Group, Ltd.WTM | 39.9/100Mixed-negative evidence64% evidence | TURNING | 21.5/35 Income 69.3% · PAT 100% 71% evidence | 5.8/25 ROA 0% · ROE -0.5% · GNPA — 68% evidence | 9.8/20 P/BV 1.01× · P/BV÷ROE — 10% evidence | 2.8/20 RS sector -10.2% · RS bench -7.5% · 1Y 16.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 5.8 + 9.8 + 2.8 = 39.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Selective Insurance Group, Inc.SIGI | 39.5/100Mixed-negative evidence80% evidence | ASLEEP | 19.1/35 Income 7% · PAT 29.4% 81% evidence | 10.5/25 ROA 0.9% · ROE 3.7% · GNPA — 68% evidence | 5.1/20 P/BV 1.58× · P/BV÷ROE 0.43 70% evidence | 4.8/20 RS sector -5.4% · RS bench -2.7% · 1Y 14.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 10.5 + 5.1 + 4.8 = 39.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Chubb LimitedCB | 38.8/100Mixed-negative evidence80% evidence | BREAKING OUT | 14.6/35 Income 8% · PAT 21.5% 81% evidence | 11.7/25 ROA 1.1% · ROE 3.7% · GNPA — 68% evidence | 4.6/20 P/BV 1.74× · P/BV÷ROE 0.47 70% evidence | 7.9/20 RS sector -2.8% · RS bench 0% · 1Y 24.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 14.6 + 11.7 + 4.6 + 7.9 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Horace Mann Educators CorporationHMN | 37.1/100Mixed-negative evidence76% evidence | FADING | 17.5/35 Income 5.5% · PAT 43.9% 71% evidence | 7.5/25 ROA 0.3% · ROE 2.9% · GNPA — 68% evidence | 5.3/20 P/BV 1.17× · P/BV÷ROE 0.4 70% evidence | 6.8/20 RS sector -3.2% · RS bench -0.4% · 1Y 7.7%9 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 7.5 + 5.3 + 6.8 = 37.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Stewart Information Services CorporationSTC | 36.9/100Mixed-negative evidence60% evidence | ASLEEP | 17.5/35 Income — · PAT — 26% evidence | 12.5/25 ROA 1.6% · ROE 2.7% · GNPA — 68% evidence | 4.8/20 P/BV 1.21× · P/BV÷ROE 0.45 70% evidence | 2.1/20 RS sector -13.1% · RS bench -10.7% · 1Y -12.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 12.5 + 4.8 + 2.1 = 36.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25American Financial Group, Inc.AFG | 33.8/100Adverse evidence76% evidence | BREAKING OUT | 12.0/35 Income -1.2% · PAT 10% 71% evidence | 9.8/25 ROA 0.6% · ROE 4.2% · GNPA — 68% evidence | 4.1/20 P/BV 2.27× · P/BV÷ROE 0.54 70% evidence | 7.9/20 RS sector -4.2% · RS bench -1.5% · 1Y 1.2%4 of 12 weeks ahead 100% evidence |
| Exact sum: 12 + 9.8 + 4.1 + 7.9 = 33.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26CNA Financial CorporationCNA | 32.7/100Adverse evidence76% evidence | BREAKING OUT | 14.4/35 Income 4% · PAT 35.8% 71% evidence | 7.7/25 ROA 0.3% · ROE 2% · GNPA — 68% evidence | 4.2/20 P/BV 1.14× · P/BV÷ROE 0.57 70% evidence | 6.4/20 RS sector -7.5% · RS bench -4.9% · 1Y 5.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 7.7 + 4.2 + 6.4 = 32.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Loews CorporationL | 29.8/100Adverse evidence76% evidence | TURNING | 14.8/35 Income 4.2% · PAT 23.8% 71% evidence | 7.8/25 ROA 0.5% · ROE 1.9% · GNPA — 68% evidence | 4.0/20 P/BV 1.17× · P/BV÷ROE 0.62 70% evidence | 3.2/20 RS sector -8% · RS bench -5.3% · 1Y 12.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 7.8 + 4 + 3.2 = 29.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Kemper CorporationKMPR | 25.0/100Thin evidence · provisional58% evidence | TURNING | 6.2/35 Income 0.3% · PAT -90.6% 71% evidence | 5.7/25 ROA 0% · ROE -0.2% · GNPA — 68% evidence | 9.8/20 P/BV 0.68× · P/BV÷ROE — 10% evidence | 3.3/20 RS sector -27.3% · RS bench -25.4% · 1Y -47.1%4 of 12 weeks ahead 70% evidence |
| Exact sum: 6.2 + 5.7 + 9.8 + 3.3 = 25 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Porch Group, Inc.PRCH | 47.5/100Thin evidence · provisional48% evidence | BREAKING OUT | 13.2/35 Income — · PAT — 26% evidence | 4.6/25 ROA -0.5% · ROE -164.7% · GNPA — 68% evidence | 9.8/20 P/BV -143.74× · P/BV÷ROE — 10% evidence | 19.9/20 RS sector 28.3% · RS bench 31.6% · 1Y -15.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 4.6 + 9.8 + 19.9 = 47.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30Lemonade, Inc.LMND | 30.5/100Thin evidence · provisional48% evidence | ASLEEP | 17.4/35 Income — · PAT — 26% evidence | 4.1/25 ROA -2.2% · ROE -8.5% · GNPA — 68% evidence | 9.0/20 P/BV 10× · P/BV÷ROE — 10% evidence | 0.0/20 RS sector -29.6% · RS bench -27.7% · 1Y -20.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 4.1 + 9 + 0 = 30.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is RLI Corp.'s stock price today?
RLI Corp. trades at $60.5, −6.3% over the past year. The company is valued at $6.0 B. The stock sits at 69% of its 52-week range of $49–$66, +2.3% versus its 200-day average. On the tape, the price is topping out, 12 weeks in. — as of 17 September 2026.
What were RLI Corp.'s latest quarterly results?
RLI Corp. reported total income of $0.4 B and net profit of $0.1 B for the Mar 26 quarter. Income rose 2.4% and profit fell 16.7% year on year. Earnings per share were $0.60. The net margin was 11.9%, 2.7 pp lower than a year earlier. — as of 17 September 2026.
What is RLI Corp.'s revenue?
RLI Corp. reported revenue of $0.4 B in the Mar 26 quarter, +2.4% year on year. For the full FY25 fiscal year, revenue was $1.9 B (+6.2%). Over the last 4 years revenue compounded at 12.3% a year. — as of 17 September 2026.
What is RLI Corp.'s profit?
RLI Corp. earned $0.1 B of net profit in the Mar 26 quarter, −16.7% year on year. Full-year FY25 profit was $0.4 B. The net margin ran 11.9% in the latest quarter. — as of 17 September 2026.
What is RLI Corp.'s market cap?
RLI Corp.'s market capitalisation is $6.0 B at a stock price of $60.5. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.
What is RLI Corp.'s P/BV ratio?
RLI Corp. trades at a P/BV of 3.2×, at the 11th percentile of its own 5-year range, against a long-run median of 4.3×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.
Does RLI Corp. pay a dividend?
Yes — RLI Corp. declared $0.16 per share for Mar 26, and $0.64 per share across the last four reported quarters. The latest quarter is up 6.7% on the same quarter a year earlier. — as of 17 September 2026.
What is RLI Corp.'s dividend per share?
RLI Corp.'s most recently declared dividend is $0.16 per share for Mar 26, giving $0.64 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 17 September 2026.
What is RLI Corp.'s dividend yield?
RLI Corp.'s trailing dividend yield is 1.06%: $0.64 declared per share across the last four reported quarters, against a share price of $60.5. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 17 September 2026.
Is RLI Corp. overvalued?
On its own history, RLI Corp. looks cheap: its P/BV of 3.2× has been cheaper only 11% of the time in 5 years (long-run median 4.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 17 September 2026.
Is RLI Corp. growing?
Not right now — RLI Corp.'s latest numbers are shrinking: latest-quarter revenue +2.4% year on year, profit −16.7%, and the net margin −2.7 pp at 11.9%. The 4-year compound rates are 12.3% (revenue) and 9.3% (profit). The earnings engine currently reads: deteriorating — as of 17 September 2026.
How is RLI Corp. performing?
RLI Corp. is topping out, 12 weeks in. Its latest quarter's income rose 2.4% and profit fell 16.7% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 17 September 2026.
What stage is RLI Corp. in?
Improving — profit growth bottomed 8 quarters ago at −49.2% and has held its recovery at +35.7%, ROE lifting at 21.1%. The read comes from the last 12 quarters of growth (revenue growth +9.2% latest, profit growth +35.7% latest, eps growth +40.8% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.
Is RLI Corp. in an uptrend?
It is stalling — the price is topping out (week 12 of stage 3), trading +2.3% versus its 200-day average and at 69% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.
Is RLI Corp. beating the market?
On recent form, yes — RLI Corp. has been ahead of the S&P 500 on a trailing-13-week view for 9 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +78% against the S&P 500's +255% — behind the index over the full window. — as of 17 September 2026.
Will RLI Corp.'s stock price go up?
This page publishes no price forecast for RLI Corp. What it measures instead: the stock price is $60.5, the price is topping out 12 weeks in. Its P/BV of 3.2× sits at the 11th percentile of its own 5-year range. Direction is not something this site claims to know. — as of 17 September 2026.
Is the market betting against RLI Corp.?
Yes — short interest is 10.3% of RLI Corp.'s tradable float, about 13.4 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.
Where is RLI Corp. in its business cycle?
RLI Corp.'s FY25 net margin was 21.3%, against a 5-year band of 19.8%–34.1%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 11.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.
What could break the RLI Corp. story?
The sharpest disagreement: the P/BV sits at the 11th percentile of its own range, but the engine is deteriorating — cheap for a reason until the quarters turn. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.
Is RLI Corp. a stock worth studying right now?
This is not investment advice. The machine read: RLI Corp. is cheap for a reason. The P/BV sits at the 11th percentile of its own range, and the quarters are still getting worse. The sharpest open question: whether the quarters turn before the discount closes. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.
Not SEBI Registered !! Not Investment advice !!